Business Wire

The ADHD Expert Consortium Convenes for Fourth Annual Meeting

HOUSTON--(BUSINESS WIRE)--The ADHD Expert Consortium, a diverse group of professionals advocating for improved ADHD care, held its fourth annual meeting in Houston, Texas. This year’s meeting focused ...
Nasdaq

Cingulate Inc. Submits Phase 3 Safety Data for CTx-1301 Ahead of FDA Meeting on ADHD Treatment

Cingulate Inc. submitted CTx-1301 Phase 3 safety data to the FDA, preparing for a Pre-NDA meeting on April 2, 2025. Cingulate Inc. announced the submission of Phase 3 safety data for its ADHD ...
Psychology Today

Managing ADHD in the Workplace

Do you struggle to maintain productivity at work? Here are strategies for creating sustainable success on the job.
Seeking Alpha

Cingulate Completes Pre-NDA Meeting with FDA to Discuss New Drug Application for lead ADHD Asset CTx-1301

KANSAS CITY, Kan., April 03, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (CING) (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform ...
The Ithacan

Support center expands programming for students with ADHD

Starting in Spring 2026, programming for students with ADHD at Ithaca College has expanded from monthly workshops to body ...